文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

西非15国2001-19年麻疹消除进展记分卡:回顾性多国分析

A scorecard of progress towards measles elimination in 15 west African countries, 2001-19: a retrospective, multicountry analysis of national immunisation coverage and surveillance data.
PubMed 文献 · Lancet Glob Health · 2021-01-01

该研究回顾性分析2001-2019年西非15国国家免疫覆盖与病例监测数据,用8项指标构建麻疹消除进展记分卡。2019年区域加权平均首剂含麻疹疫苗覆盖率66%,73%国家引入第二剂;12国(80%)未达消除里程碑。2019年区域麻疹发病率是2020年消除目标(<1例/百万人口)的33倍。

要点

  • 2019年西非区域加权平均首剂MCV覆盖率为66%,较2001年45%有所提升。
  • 截至2019年12月,73%(11/15)西非国家已引入第二剂MCV。
  • 12国(80%)未达麻疹消除里程碑,佛得角、冈比亚、加纳进展显著。

核心结论

  • 2020年后麻疹将在西非持续地方性流行,区域麻疹发病率远高于消除目标。
  • 佛得角、冈比亚和加纳取得实质性进展,可为其他国家提供借鉴。

研究设计与样本

  • 回顾性多国系列分析,数据来自2001年1月1日至2019年12月31日国家免疫覆盖与病例监测数据。
  • 分析对象为西非国家经济共同体15个西非国家。
  • 使用8项指标构建国家层面麻疹总结记分卡,追踪截至2019年底的消除进展。

主要发现

  • 2019年区域加权平均首剂MCV覆盖率为66%,2001年为45%。
  • 截至2019年12月,73%(11/15)西非国家已引入第二剂MCV。
  • 2019年估计有4 588 040名12-23月龄儿童未接种首剂MCV,其中71%居住在尼日利亚。
  • 基于记分卡,12国(80%)未达麻疹消除里程碑;佛得角、冈比亚和加纳进展显著。
  • 2019年区域麻疹发病率为每百万人口33例,是2020年消除目标(<1例/百万人口)的33倍。

关键数值与推荐

  • 麻疹消除里程碑:2020年区域麻疹发病率目标为每百万人口<1例。
  • 记分卡使用8项指标评估各国麻疹消除进展。

临床怎么用

  • 利用记分卡识别免疫覆盖与监测薄弱环节,指导补充免疫活动规划。
  • 借鉴佛得角、冈比亚和加纳的经验,提升首剂与第二剂MCV覆盖率。
  • 重点关注尼日利亚等未接种儿童集中的国家,强化常规免疫与监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The WHO Regional Office for the Africa Regional Immunization Technical Advisory Group, in 2011, adopted the measles control and elimination goals for all countries of the African region to achieve in 2015 and 2020 respectively. Our aim was to track the current status of progress towards measles control and elimination milestones across 15 west African countries between 2001 and 2019. METHODS: We did a retrospective multicountry series analysis of national immunisation coverage and case surveillance data from Jan 1, 2001, to Dec 31, 2019. Our analysis focused on the 15 west African countries that constitute the Economic Community of West African States. We tracked progress in the coverage of measles-containing vaccines (MCVs), measles supplementary immunisation activities, and measles incidence rates. We developed a country-level measles summary scorecard using eight indicators to track progress towards measles elimination as of the end of 2019. The summary indicators were tracked against measles control and elimination milestones. FINDINGS: The weighted average regional first-dose MCV coverage in 2019 was 66% compared with 45% in 2001. 73% (11 of 15) of the west African countries had introduced second-dose MCV as of December, 2019. An estimated 4 588 040 children (aged 12-23 months) did not receive first-dose MCV in 2019, the majority (71%) of whom lived in Nigeria. Based on the scorecard, 12 (80%) countries are off-track to achieving measles elimination milestones; however, Cape Verde, The Gambia, and Ghana have made substantial progress. INTERPRETATION: Measles will continue to be endemic in west Africa after 2020. The regional measles incidence rate in 2019 was 33 times the 2020 elimination target of less than 1 case per million population. However, some hope exists as countries can look at the efforts made by Cape Verde, The Gambia, and Ghana and learn from them. FUNDING: None.

来源:Lancet Glob Health,查看原文。版权归原作者所有。

引用

  1. Wariri O, Nkereuwem E, Erondu NA, et al. A scorecard of progress towards measles elimination in 15 west African countries, 2001-19: a retrospective, multicountry analysis of national immunisation coverage and surveillance data. Lancet Glob Health. 2021. PMID: 33607028. doi:10.1016/S2214-109X(20)30481-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。